Capital World Investors
SANA icon

Capital World Investors’s Sana Biotechnology SANA Stock Holding History

Capital World Investors’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,449,035
Closed -$9.15M – 596
2025
Q1 		$9.15M Hold
5,449,035
– – ﹤0.01% 490
2024
Q4 		$8.88M Hold
5,449,035
– – ﹤0.01% 484
2024
Q3 		$22.7M Hold
5,449,035
– – ﹤0.01% 448
2024
Q2 		$29.8M Hold
5,449,035
– – ﹤0.01% 424
2024
Q1 		$54.5M Buy
5,449,035
+3,917,728
+256% +$29.3M 0.01% 388
2023
Q4 		$6.25M Hold
1,531,307
– – ﹤0.01% 468
2023
Q3 		$5.93M Hold
1,531,307
– – ﹤0.01% 474
2023
Q2 		$9.13M Buy
+1,531,307
New +$8.83M ﹤0.01% 461

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors's SANA Position: Q2 2025 in Review

Capital World Investors sold out of Sana Biotechnology (SANA) in Q2 2025, closing a stake of 5,449,035 shares — an estimated $9.15M sold.

Capital World Investors first reported a position in SANA in Q2 2023 and held it in 8 quarters. The position peaked at $54.5M in Q1 2024. 155 funds tracked by Wall St. Rank hold SANA as of Q2 2025.

  • Capital World Investors reported no remaining Sana Biotechnology position as of Q2 2025 after selling out during the quarter.
  • Capital World Investors sold 5,449,035 Sana Biotechnology shares in Q2 2025, an estimated $9.15M.
  • Capital World Investors first reported a position in Sana Biotechnology in Q2 2023 and held it in 8 quarters.
  • Capital World Investors's Sana Biotechnology position peaked at $54.5M in Q1 2024.
  • 155 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2025.

Based on Capital World Investors's 13F filing for Q2 2025, filed 13 Aug 2025.